Jørn Andersen - Concepedia

Author

Jørn Andersen

Also Known As

J E Andersen, J. E. ANDERSEN, J. E. Andersen, J.E. ANDERSEN, J.E. Andersen, Jorn Andersen, JØRN ANDERSEN, JØRN ERIK ANDERSEN, Jørn Andersen

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Aarhus University Hospital Rigshospitalet Danish Cancer Society Herlev Hospital

About

Jørn Andersen is an author at Odense University Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	796
2	Health Sciences	4	4	146
3	Endocrinology	3	3	184
4	Public Health	2	2	153
5	Biostatistics	1	1	70

Jørn Andersen

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA) K. Bertelsen, Anders Jakobsen, I. Strøyer, Gynecologic Oncology MedicineMetronomic TherapyGynecologyProspective Randomized ComparisonCancer Treatment	1993	154
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study. Anders Jakobsen, K. Bertelsen, Jørn Andersen, Journal of Clinical Oncology	1997	144
A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma K. Bertelsen, Anders Jakobsen, Jørn Andersen, Gynecologic Oncology Randomized StudyMedicineMetronomic TherapyGynecologyAdvanced Ovarian Carcinoma	1987	115
Germ cell function and hormonal status in patients with testicular cancer Peter Vejby Hansen, Henrik Trykker, Jørn Andersen, Cancer Serum GonadotropinsFertilityPathologyGynecologySemen Analysis	1989	83
Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer A Sell, K. Bertelsen, Jørn Andersen, Gynecologic Oncology Radiation TherapyMedicineEarly Ovarian CancerGynecologyCancer Treatment	1990	78
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer Jørn Andersen, Hans Skovgaard Poulsen Cancer	1989	73
Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer Bent Bruun Kristensen, Bent Ejlertsen, Henning T. Mouridsen, Acta Oncologica	2008	70
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays Jørn Andersen, Susan M. Thorpe, William King, European Journal of Cancer and Clinical Oncology Steroid-binding AssaysHormonal ReceptorPrognostic ValuePathologyBreast Cancer	1990	70
Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer Bent Ejlertsen, Henning T. Mouridsen, Maj‐Britt Jensen, European Journal of Cancer Breast OncologyMedicineCmf Versus CefPrimary Breast CancerRandomised Comparison	2007	63
Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases Henning Poulsen, Magnus W. Jacobsen, K. Bertelsen, International Journal of Gynecological Cancer	1996	55

Page 1